Clinical Trial Update: European Trial on Enhanced DNA Repair Inhibition in Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 European trial evaluating enhanced DNA repair inhibition in ovarian cancer has completed enrollment and posted results. The study also included fallopia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-06-11